A Study of IMPT-514 in Active Refractory Systemic Lupus Erythematosus (SLE)

Conditions: Systemic Lupus Erythematosus; Lupus Nephritis Interventions: Biological: IMPT-514; Biological: IMPT-514; Biological: IMPT-514 Sponsors: ImmPACT Bio Not yet recruiting

https://clinicaltrials.gov/study/NCT06153095

Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials

More News: Lupus | Nephritis | Research | Study